Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 26 articles: HTML format

Single Articles

August 2025
1. WANG Y, Yang K, Jiang G, Zheng X, et al
   Twist1 promoting neointima hyperplasia after vascular injury in diabetes via regulating hyperglycemia-induced phenotype switching of vascular smooth muscle cells.
   Atherosclerosis. 2025;409:120496.
   PubMed     Abstract available
   
   
   
2. KITAHARA S, Kataoka Y, Nicholls SJ, Funabashi S, et al
   Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trial.
   Atherosclerosis. 2025;409:120470.
   PubMed     Abstract available
   
   
   July 2025
3. HE D, Li C, Yang C, Wang J, et al
   Difference between cystatin C- and creatinine-based estimated glomerular filtration rate, diabetes status, and incident peripheral artery disease: A population-based cohort study.
   Atherosclerosis. 2025;408:120452.
   PubMed     Abstract available
   
   
   
4. SVENDSEN K, Christensen JJ, Igland J, Krogh HW, et al
   Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia.
   Atherosclerosis. 2025;408:120442.
   PubMed     Abstract available
   
   
   June 2025
5. CAO BF, Liu K, Chen HW, Xu ZY, et al
   Impact of baseline and trajectory of the cardiometabolic indices on incident microvascular complications in patients with type 2 diabetes.
   Atherosclerosis. 2025;407:120407.
   PubMed     Abstract available
   
   
   March 2025
6. RIKHI R, Haidar A, Bhatia HS, Beam K, et al
   Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA).
   Atherosclerosis. 2025;404:119179.
   PubMed     Abstract available
   
   
   February 2025
7. KRUGER A, Willems van Dijk K, van Heemst D, Noordam R, et al
   Long-term body mass index trajectories and the risk of type 2 diabetes mellitus and atherosclerotic cardiovascular disease using healthcare data from UK Biobank participants.
   Atherosclerosis. 2025;403:119135.
   PubMed     Abstract available
   
   
   January 2025
8. SUN M, Lu Z, Chen WM, Lv S, et al
   N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus.
   Atherosclerosis. 2025;402:119117.
   PubMed     Abstract available
   
   
   
9. MUELLER M, Charwat-Resl S, Schulze-Bauer HS, Nguyen C, et al
   Vascular strain of the aorta and peripheral arteries in patients with type 1 diabetes mellitus in comparison with healthy controls.
   Atherosclerosis. 2025;402:119106.
   PubMed     Abstract available
   
   
   October 2024
10. JIMENEZ-SANCHEZ C, Oberhauser L, Maechler P
    Role of fatty acids in the pathogenesis of ss-cell failure and Type-2 diabetes.
    Atherosclerosis. 2024 Oct 4:118623. doi: 10.1016/j.atherosclerosis.2024.118623.
    PubMed     Abstract available
    
    
    September 2024
11. UNGER E, Makarova N, Borof K, Schlieker P, et al
    Association of adverse pregnancy outcomes with cardiovascular risk profiles in later life: Current insights from the Hamburg City Health Study (HCHS).
    Atherosclerosis. 2024;396:118526.
    PubMed     Abstract available
    
    
    August 2024
12. CHEN JX, Lu Q, Geng T, Wang Y, et al
    Differences in HDL-related coronary heart disease risk between individuals with and without diabetes.
    Atherosclerosis. 2024;397:118553.
    PubMed     Abstract available
    
    
    
13. LIU WX, Hu YF, Tai GJ, Li YP, et al
    Macrophages regulate plaque progression in diabetic Apoe(-/-) mice dependent on Pi4p/Nlrp3 signaling pathway.
    Atherosclerosis. 2024;397:118556.
    PubMed     Abstract available
    
    
    
14. GROENEN AG, Halmos B, van Zeventer IA, Salzbrunn JB, et al
    Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetes.
    Atherosclerosis. 2024;395:117609.
    PubMed     Abstract available
    
    
    July 2024
15. AJAY AK, Zhu LJ, Zhao L, Liu Q, et al
    Local vascular Klotho mediates diabetes-induced atherosclerosis via ERK1/2 and PI3-kinase-dependent signaling pathways.
    Atherosclerosis. 2024;396:118531.
    PubMed     Abstract available
    
    
    
16. WESTCOTT F, Dearlove DJ, Hodson L
    Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk.
    Atherosclerosis. 2024;394:117237.
    PubMed     Abstract available
    
    
    
17. BECHMANN LE, Emanuelsson F, Nordestgaard BG, Benn M, et al
    SGLT2-inhibition increases total, LDL, and HDL cholesterol and lowers triglycerides: Meta-analyses of 60 randomized trials, overall and by dose, ethnicity, and drug type.
    Atherosclerosis. 2024;394:117236.
    PubMed     Abstract available
    
    
    June 2024
18. GAGNON E, Bourgault J, Gobeil E, Theriault S, et al
    Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
    Atherosclerosis. 2024;393:117558.
    PubMed     Abstract available
    
    
    May 2024
19. BOREN J, Oorni K, Catapano AL
    The link between diabetes and cardiovascular disease.
    Atherosclerosis. 2024 May 29:117607. doi: 10.1016/j.atherosclerosis.2024.117607.
    PubMed    
    
    
    
20. ROSENSON RS, Tate A, Mar P, Grushko O, et al
    Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects.
    Atherosclerosis. 2024;392:117529.
    PubMed     Abstract available
    
    
    April 2024
21. DARDANO A, Bianchi C, Garofolo M, Del Prato S, et al
    The current landscape for diabetes treatment: Preventing diabetes-associated CV risk.
    Atherosclerosis. 2024 Apr 23:117560. doi: 10.1016/j.atherosclerosis.2024.117560.
    PubMed     Abstract available
    
    
    
22. LUCIANI L, Pedrelli M, Parini P
    Modification of lipoprotein metabolism and function driving atherogenesis in diabetes.
    Atherosclerosis. 2024 Apr 17:117545. doi: 10.1016/j.atherosclerosis.2024.117545.
    PubMed     Abstract available
    
    
    
23. ARSENAULT BJ, Carpentier AC, Poirier P, Despres JP, et al
    Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index.
    Atherosclerosis. 2024 Apr 14:117546. doi: 10.1016/j.atherosclerosis.2024.117546.
    PubMed     Abstract available
    
    
    March 2024
24. DING X, Qiu Y, Wu G, Li S, et al
    l-thyroxine attenuates extracellular Hsp90alpha-induced vascular endothelial calcification in diabetes mellitus, as revealed by parallel metabolic profiles.
    Atherosclerosis. 2024;392:117527.
    PubMed     Abstract available
    
    
    
25. VARGAS-VAZQUEZ A, Fermin-Martinez CA, Antonio-Villa NE, Fernandez-Chirino L, et al
    Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes.
    Atherosclerosis. 2024 Mar 13:117508. doi: 10.1016/j.atherosclerosis.2024.117508.
    PubMed     Abstract available
    
    
    February 2024
26. KIM H, Choi CU, Rhew K, Park J, et al
    Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: A network meta-analysis.
    Atherosclerosis. 2024;391:117490.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.